{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:49:40Z","timestamp":1760298580659},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of this study was to evaluate the clinical outcome after seven-day artesunate monotherapy for uncomplicated <jats:italic>Plasmodium falciparum<\/jats:italic> malaria in Yingjiang County along the China-Myanmar border and investigate genetic polymorphisms in the <jats:italic>P. falciparum<\/jats:italic> chloroquine-resistance transporter (<jats:italic>pfcrt<\/jats:italic>), multidrug resistance 1 (<jats:italic>pfmdr1<\/jats:italic>), dihydrofolate reductase (<jats:italic>pfdhfr<\/jats:italic>), dihydropteroate synthase (<jats:italic>pfdhps<\/jats:italic>) and ATPase (<jats:italic>pfatp6<\/jats:italic>) genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients\u2009\u2265\u2009one year of age with fever (axillary temperature \u226537.5\u00b0C) or history of fever and <jats:italic>P. falciparum<\/jats:italic> mono-infection were included. Patients received anti-malarial treatment with artesunate (total dose of 16\u2009mg\/kg over seven days) by directly observed therapy. After a 28-day follow-up, treatment efficacy and effectiveness were assessed based on clinical and parasitological outcomes. Treatment failure was defined as recrudescence of the original parasite and distinguished with new infection confirmed by PCR. Analysis of gene mutation and amplification were performed by nested polymerase chain reaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sixty-five patients were enrolled; 10 withdrew from the study, and six were lost to follow-up. All but two patients demonstrated adequate clinical and parasitological response; 12 had detectable parasitaemia on day 3. These two patients were confirmed to be new infection by PCR. The efficacy of artesunate was 95.9%. The <jats:italic>pfcrt<\/jats:italic> mutation in codon 76 was found in all isolates (100%), and mutations in codons 71 and 72 were found in 4.8% of parasite isolates. No mutation of <jats:italic>pfmdr1<\/jats:italic> (codons 86 or 1246) was found. Among all samples, 5.1% were wild type for <jats:italic>pfdhfr<\/jats:italic>, whereas the other samples had mutations in four codons (51, 59, 108 and 164), and mutations in <jats:italic>pfdhps<\/jats:italic> (codons 436, 437, 540 and 581) were found in all isolates. No samples had mutations in <jats:italic>pfatp6<\/jats:italic> codons 623 or 769, but two new mutations (N683K and R756K) were found in 4.6% and 9.2% of parasite isolates, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\n              <jats:italic>Plasmodium falciparum<\/jats:italic> infection was associated with slow parasite clearance and suspected artemisinin resistance at the China-Myanmar border area. The prevalence of <jats:italic>pfcrt<\/jats:italic> 76\u2009T and markers for SP resistance are still high. It should be strengthened further on parasite clearance time or clearance half life to confirm the resistance status, and molecular epidemiology should provide complementary information to assess the appropriateness of current policies based on artemisinin derivatives.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-11-278","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T12:15:04Z","timestamp":1345119304000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border"],"prefix":"10.1186","volume":"11","author":[{"given":"Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuisen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"2468_CR1","volume-title":"WHO Malaria report","author":"WHO","year":"2009","unstructured":"WHO: WHO Malaria report. 2009, Geneva: World Health Organization"},{"key":"2468_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-67. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"2468_CR3","volume-title":"Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010","author":"WHO","year":"2010","unstructured":"WHO: Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010. 2010, Geneva: World Health Organization"},{"key":"2468_CR4","volume-title":"World malaria report","author":"WHO","year":"2010","unstructured":"WHO: World malaria report. 2010, Geneva: World Health Organization"},{"key":"2468_CR5","first-page":"401","volume":"29","author":"SS Zhou","year":"2011","unstructured":"Zhou SS, Wang Y, Li Y: Malaria situation in the People\u2019s Republic of China in 2010. Chin J Parasitol Parasit Dis. 2011, 29: 401-403.","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"2468_CR6","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2010","unstructured":"WHO: Guidelines for the treatment of malaria. 2010, World Health Organization"},{"key":"2468_CR7","unstructured":"Antimalarial drug policy in China. http:\/\/www.moh.gov.cn\/publicfiles\/business\/htmlfiles\/mohjbyfkzj\/s3594\/200907\/41610.htm."},{"key":"2468_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001, 344: 257-263. 10.1056\/NEJM200101253440403.","journal-title":"N Engl J Med"},{"key":"2468_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4269\/ajtmh.2007.76.844","volume":"76","author":"J Ursing","year":"2007","unstructured":"Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP: Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am J Trop Med Hyg. 2007, 76: 844-848.","journal-title":"Am J Trop Med Hyg"},{"key":"2468_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P: A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009, 8: 89-10.1186\/1475-2875-8-89.","journal-title":"Malar J"},{"key":"2468_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1086\/320195","volume":"183","author":"HA Babiker","year":"2001","unstructured":"Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D: High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis. 2001, 183: 1535-1538. 10.1086\/320195.","journal-title":"J Infect Dis"},{"key":"2468_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.2000.62.271","volume":"62","author":"LK Basco","year":"2000","unstructured":"Basco LK, Ringwald P: Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg. 2000, 62: 271-276.","journal-title":"Am J Trop Med Hyg"},{"key":"2468_CR13","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1111\/j.1742-4658.2007.05999.x","volume":"274","author":"JE Hyde","year":"2007","unstructured":"Hyde JE: Drug-resistant malaria - an insight. FEBS J. 2007, 274: 4688-4698. 10.1111\/j.1742-4658.2007.05999.x.","journal-title":"FEBS J"},{"key":"2468_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002, 185: 380-388. 10.1086\/338566.","journal-title":"J Infect Dis"},{"key":"2468_CR15","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/587845","volume":"197","author":"C Lynch","year":"2008","unstructured":"Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C: Emergence of a dhfr mutation conferring highlevel drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008, 197: 1598-1604. 10.1086\/587845.","journal-title":"J Infect Dis"},{"key":"2468_CR16","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/AAC.01459-07","volume":"52","author":"M Imwong","year":"2008","unstructured":"Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ: Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother. 2008, 52: 2657-2659. 10.1128\/AAC.01459-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2468_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nsmb947","volume":"12","author":"AC Uhlemann","year":"2005","unstructured":"Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S: A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol. 2005, 12 (7): 628-9. 10.1038\/nsmb947.","journal-title":"Nat Struct Mol Biol"},{"key":"2468_CR18","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","author":"WHO","year":"2008","unstructured":"WHO: Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. 2008, Geneva: World Health Organization, http:\/\/www.who.int\/malaria\/resistance."},{"key":"2468_CR19","unstructured":"Australian New Zealand Clinical Trials Registry. https:\/\/www.anzctr.org.au."},{"key":"2468_CR20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/AAC.47.4.1347-1354.2003","volume":"47","author":"RJ Pearce","year":"2003","unstructured":"Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother. 2003, 47: 1347-1354. 10.1128\/AAC.47.4.1347-1354.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"2468_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","volume":"12","author":"JT Lin","year":"2010","unstructured":"Lin JT, Juliano JJ, Wongsrichanalai C: Drug-resistance malaria: the era of ACT. Curr Infect Dis Rep. 2010, 12: 165-173. 10.1007\/s11908-010-0099-y.","journal-title":"Curr Infect Dis Rep"},{"key":"2468_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"AB Sidhu","year":"2002","unstructured":"Sidhu AB, Verdier-Pinard D, Fidock DA: Chloroquine resistance in Plasomodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002, 298: 210-213. 10.1126\/science.1074045.","journal-title":"Science"},{"key":"2468_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(00)00201-2","volume":"108","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC: The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000, 108: 13-23. 10.1016\/S0166-6851(00)00201-2.","journal-title":"Mol Biochem Parasitol"},{"key":"2468_CR24","first-page":"241","volume":"10","author":"DQ Liu","year":"1992","unstructured":"Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y: Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992, 10: 241-244.","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"2468_CR25","first-page":"135","volume":"23","author":"YY Guan","year":"2005","unstructured":"Guan YY, Tang LH, Hu L, Feng XP, Liu DQ: The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province. Chin J Parasitol Parasit Dis. 2005, 23: 135-139.","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"2468_CR26","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-3156.2007.01882.x","volume":"12","author":"Z Yang","year":"2007","unstructured":"Yang Z, Zhang Z, Sun X, Wan W, Cui L: Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Trop Med Int Health. 2007, 12: 1051-60. 10.1111\/j.1365-3156.2007.01882.x.","journal-title":"Trop Med Int Health"},{"key":"2468_CR27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1365-3156.2009.02342.x","volume":"14","author":"GQ Zhang","year":"2009","unstructured":"Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH: Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Trop Med Int Health. 2009, 14: 1266-71. 10.1111\/j.1365-3156.2009.02342.x.","journal-title":"Trop Med Int Health"},{"key":"2468_CR28","first-page":"32","volume":"2","author":"SX Zhang","year":"1965","unstructured":"Zhang SX: Efficiency of Pyrimethamine combined with primaquine for radical treatment of P.vivax. Xinyang Medical and Health compilation. 1965, 2: 32-unpublished data","journal-title":"Xinyang Medical and Health compilation"},{"key":"2468_CR29","first-page":"246","volume":"4","author":"RZ Wang","year":"1981","unstructured":"Wang RZ: Efficiency of pyrimethamine salt for P.vivax prophylaxis. Railway Medicine. 1981, 4: 246-247.","journal-title":"Railway Medicine"},{"key":"2468_CR30","first-page":"244","volume":"77","author":"MN Ejov","year":"1999","unstructured":"Ejov MN, Tun T, Aung S, Sein K: Response of falciparum malaria to different antimalarials in Myanmar. Bull World Health Organ. 1999, 77: 244-249.","journal-title":"Bull World Health Organ"},{"key":"2468_CR31","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","volume":"94","author":"T Triglia","year":"1997","unstructured":"Triglia T, Menting JG, Wilson C, Cowman AF: Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci. 1997, 94: 13944-13949. 10.1073\/pnas.94.25.13944.","journal-title":"Proc Natl Acad Sci"},{"key":"2468_CR32","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","volume":"366","author":"R Jambou","year":"2005","unstructured":"Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O: Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005, 366: 1960-1963. 10.1016\/S0140-6736(05)67787-2.","journal-title":"Lancet"},{"key":"2468_CR33","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1128\/AAC.00684-09","volume":"53","author":"L Bertaux","year":"2009","unstructured":"Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D: New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Antimicrob Agents Chemother. 2009, 53: 4570-4571. 10.1128\/AAC.00684-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"2468_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.meegid.2008.02.002","volume":"8","author":"S Dahlstr\u00f6m","year":"2008","unstructured":"Dahlstr\u00f6m S, Veiga MI, Ferreira P, M\u00e5rtensson A, Kaneko A, Andersson B, Bj\u00f6rkman A, Gil JP: Diversity of the sarco\/endoplasmic reticulum Ca2\u2009+\u2009\u2212ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol. 2008, 8: 340-345. 10.1016\/j.meegid.2008.02.002.","journal-title":"Infect Genet Evol"},{"key":"2468_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-2875-8-28","volume":"8","author":"ML Ibrahim","year":"2009","unstructured":"Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB: Polymorphism of PfATPase in Niger: detection of three new point mutations. Malar J. 2009, 8: 28-10.1186\/1475-2875-8-28.","journal-title":"Malar J"},{"key":"2468_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.parint.2007.12.004","volume":"57","author":"M Menegon","year":"2008","unstructured":"Menegon M, Sannella AR, Majori G, Severini C: Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Parasitol Int. 2008, 57: 233-235. 10.1016\/j.parint.2007.12.004.","journal-title":"Parasitol Int"},{"key":"2468_CR37","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016\/S0140-6736(12)60484-X.","journal-title":"Lancet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:09:56Z","timestamp":1630526996000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2468"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-278","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]},"assertion":[{"value":"8 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"278"}}